Hepatitis D Virus: Introduction and Epidemiology

Overview

Journal Cold Spring Harb Perspect Med

Specialty General Medicine

Date 2015 Jul 3

PMID 26134842

Citations 57

Authors

Mario Rizzetto

Affiliations

Soon will be listed here.

Abstract

Hepatitis D is caused by the hepatitis D virus (HDV), a unique RNA pathogen that requires the hepatitis B surface antigen (HBsAg) to infect. Hepatitis D is transmitted by the parenteral route. The main susceptible group is patients with chronic HBsAg infection who become superinfected with the virus. Hepatitis D occurs throughout the globe, but control of hepatitis B virus (HBV) in the last two decades has consistently diminished the circulation of HDV in industrialized countries. However, hepatitis D remains a medical issue for injecting drug users (IDUs), as well as immigrants from endemic HDV areas, who are reintroducing the infection in Europe.

Citing Articles

A US-Based Multi-Site Pilot to Screen Hepatitis B Surface Antigen-Positive Patients for Hepatitis D.

Li M, Hunt B, Balani B, Ogedegbe C, Gordon P, Hayden J J Viral Hepat. 2024; 32(1):e14043.

PMID: 39668640 PMC: 11638661. DOI: 10.1111/jvh.14043.

Seroprevalence and risk factors of hepatitis B, C and D virus infection amongst patients with features of hepatitis in a referral hospital in Botswana: A cross-sectional study.

Souda S, Mwita J, Cainelli F, Mannathoko N, Anderson M, Moyo S S Afr J Infect Dis. 2024; 36(1):275.

PMID: 39372168 PMC: 11451164. DOI: 10.4102/sajid.v36i1.275.

Molecular Epidemiology of Hepatitis D Virus in the North-East Region of Romania.

Grecu L, Pavel-Tanasa M, Matei L, Sultana C, Ruta S, Grecu R Pathogens. 2024; 13(9).

PMID: 39338984 PMC: 11435033. DOI: 10.3390/pathogens13090793.

vHDvDB 2.0: Database and Group Comparison Server for Hepatitis Delta Virus.

Lee C, Lau Y, Liang Y, Hsian Y, Lin C, Wu H Viruses. 2024; 16(8).

PMID: 39205227 PMC: 11359145. DOI: 10.3390/v16081254.

Dismantling Barriers to Hepatitis B and Delta Screening, Prevention, and Linkage to Care among the PWUD Community in Philadelphia.

Zovich B, Freeland C, Moore H, Sapp K, Qureshi A, Holbert R Viruses. 2024; 16(4).

PMID: 38675969 PMC: 11054430. DOI: 10.3390/v16040628.

References

Foupouapouognigni Y, Noah Noah D, Sartre M, Njouom R . High prevalence and predominance of hepatitis delta virus genotype 1 infection in Cameroon. J Clin Microbiol. 2011; 49(3):1162-4. PMC: 3067734. DOI: 10.1128/JCM.01822-10. View

Zaidi G, Idrees M, Malik F, Amin I, Shahid M, Younas S . Prevalence of hepatitis delta virus infection among hepatitis B virus surface antigen positive patients circulating in the largest province of Pakistan. Virol J. 2010; 7:283. PMC: 2988018. DOI: 10.1186/1743-422X-7-283. View

Cross T, Rizzi P, Horner M, Jolly A, Hussain M, Smith H . The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol. 2007; 80(2):277-82. DOI: 10.1002/jmv.21078. View

Ponzetto A, Negro F, Popper H, Bonino F, Engle R, Rizzetto M . Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees. Hepatology. 1988; 8(6):1655-61. DOI: 10.1002/hep.1840080631. View

Rizzetto M, Ciancio A . Epidemiology of hepatitis D. Semin Liver Dis. 2012; 32(3):211-9. DOI: 10.1055/s-0032-1323626. View

Saravanan S, Velu V, Kumarasamy N, Shankar E, Nandakumar S, Murugavel K . Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India. Trans R Soc Trop Med Hyg. 2008; 102(8):793-6. DOI: 10.1016/j.trstmh.2008.05.001. View

Moatter T, Abbas Z, Shabir S, Jafri W . Clinical presentation and genotype of hepatitis delta in Karachi. World J Gastroenterol. 2007; 13(18):2604-7. PMC: 4146823. DOI: 10.3748/wjg.v13.i18.2604. View

Genne D, Rossi I . Hepatitis delta in Switzerland: a silent epidemic. Swiss Med Wkly. 2011; 141:w13176. DOI: 10.4414/smw.2011.13176. View

Duraisamy G, Zuridah H, Ariffin Y, Kek C . Hepatitis delta virus in intravenous drug users in Kuala Lumpur. Med J Malaysia. 1994; 49(3):212-6. View

10.

Rizzetto M . Hepatitis D: thirty years after. J Hepatol. 2009; 50(5):1043-50. DOI: 10.1016/j.jhep.2009.01.004. View

11.

Baig S, Siddiqui A, Ahmed W, Qureshi H, Arif A . Frequency of hepatitis C and D super infection in patients with hepatitis B related complex liver disorders. J Coll Physicians Surg Pak. 2009; 19(11):699-703. DOI: 11.2009/JCPSP.699703. View

12.

Kucirka L, Farzadegan H, Feld J, Mehta S, Winters M, Glenn J . Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. J Infect Dis. 2010; 202(6):845-52. PMC: 2924454. DOI: 10.1086/655808. View

13.

Arakawa Y, Moriyama M, Taira M, Hayashi N, Tanaka N, Okubo H . Molecular analysis of hepatitis D virus infection in Miyako Island, a small Japanese island. J Viral Hepat. 2000; 7(5):375-81. DOI: 10.1046/j.1365-2893.2000.00244.x. View

14.

Murhekar M, Murhekar K, Arankalle V, Sehgal S . Hepatitis delta virus infection among the tribes of the Andaman and Nicobar Islands, India. Trans R Soc Trop Med Hyg. 2005; 99(7):483-4. DOI: 10.1016/j.trstmh.2004.10.002. View

15.

Servant-Delmas A, Le Gal F, Gallian P, Gordien E, Laperche S . Increasing prevalence of HDV/HBV infection over 15 years in France. J Clin Virol. 2013; 59(2):126-8. DOI: 10.1016/j.jcv.2013.11.016. View

16.

Rosina F, Conoscitore P, Cuppone R, Rocca G, Giuliani A, Cozzolongo R . Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology. 1999; 117(1):161-6. DOI: 10.1016/s0016-5085(99)70563-9. View

17.

Wedemeyer H, Manns M . Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010; 7(1):31-40. DOI: 10.1038/nrgastro.2009.205. View

18.

Farci P . Delta hepatitis: an update. J Hepatol. 2004; 39 Suppl 1:S212-9. DOI: 10.1016/s0168-8278(03)00331-3. View

19.

Popescu G, Otelea D, Gavriliu L, Neaga E, Popescu C, Paraschiv S . Epidemiology of hepatitis D in patients infected with hepatitis B virus in bucharest: a cross-sectional study. J Med Virol. 2013; 85(5):769-74. DOI: 10.1002/jmv.23524. View

20.

Bakhshipour A, Mashhadi M, Mohammadi M, Nezam S . Seroprevalence and risk factors of hepatitis delta virus in chronic hepatitis B virus infection in Zahedan. Acta Med Iran. 2013; 51(4):260-4. View